No Data
Analysts Are Bullish on These Healthcare Stocks: Clene (CLNN), I-MAB (IMAB)
Maxim Group Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $20
Clene's CNM-Au8 Shows Promise in ALS Treatment Despite Trial Setbacks: A Strong Buy Recommendation
Clene Is Maintained at Buy by EF Hutton
H.C. Wainwright Maintains Clene(CLNN.US) With Buy Rating, Maintains Target Price $31
Buy Rating Justified by Regulatory Progress and Positive ALS Treatment Data for Clene's CNM-Au8
This_Guy : day traders?